Startups

VIB (Flanders Institute for Biotechnology)
Ghent, Flanders, Belgium
VIB, legally Vlaams Instituut voor Biotechnologie - Flanders Institute for Biotechnology, is an independent Belgian nonprofit life-sciences research institute. Belgian enterprise register 0456343923 identifies an active association established July 6, 1995, headquartered at Suzanne Tassierstraat 1 in Ghent. Operational since 1996, it combines strategic basic research with technology transfer in partnership with Ghent University, KU Leuven, University of Antwerp, Vrije Universiteit Brussel and Hasselt University. Its centers cover neuroscience, molecular neurology, cancer, inflammation, microbiology, structural biology, plant biology and computational biology/AI. Christine Durinx and Jérôme Van Biervliet are current published managing directors, with Ajit Shetty as board chair. The institution-wide scientific committee and legal board are distinguished from general management, innovation/business employees and government observers with advisory votes. Its Innovation and Business division integrates IP, venture creation, business development, discovery research, AI Studio and biotope startup incubation. The public headquarters directory supplies named roles and authentic portraits; initials avatars are excluded. Source-verified institutional equity investments include several Augustine Therapeutics financings. Licensing, spin-off origin, a press announcement or a research partnership alone does not establish a cash investment. VIB is separate from V-Bio Ventures, the independent manager in which VIB invested and has preferred deal flow, and from the separate legal Biotope Ventures vehicles. Biotope’s 2023 first close of EUR4.5 million and 2025 Fund II first close of EUR5 million involve VIB as a cornerstone investor; the EUR9 million target is not closed cash, and these external vehicles are not VIB operating budgets or institution-managed LP funds. Research funding, partner venture fundraising and public allocations have distinct meanings. The profile covers public management, scientific governance and the complete published Innovation and Business division. Rik Audenaert’s legal daily-governance appointment is distinguished from his historical CFO title, while former managing director Johan Cardoen is explicitly memorial.
Founded 1995































































































